A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Steady-state Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Oct 2017
Price : $35 *
At a glance
- Drugs Tavapadon (Primary) ; Itraconazole
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Pfizer
- 02 Oct 2017 Status changed from recruiting to completed.
- 14 Aug 2017 Planned End Date changed from 10 Aug 2017 to 14 Sep 2017.
- 14 Aug 2017 Planned primary completion date changed from 10 Aug 2017 to 14 Sep 2017.